Diseases, Conditions, Syndromes

Swiss giant Novartis halts COVID-19 hydroxychloroquine study

Swiss pharmaceuticals giant Novartis has decided to halt a clinical trial of hydroxychloroquine as a treatment for COVID-19, citing problems in recruiting enough patients for the study of the controversial drug.

Diseases, Conditions, Syndromes

New COVID-19 guidelines disrupt infertility care

The COVID-19 pandemic has resulted in people putting so many aspects of their lives—from planned vacations to birthday parties to weddings—on hold.

page 5 from 9